Continuous low plasma concentrations of everolimus provides equivalent efficacy to oral daily dosing in mouse xenograft models of human cancer
Crossref DOI link: https://doi.org/10.1007/s00280-017-3407-5
Published Online: 2017-08-04
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Laborde, Laurent
Oz, Fatos
Ristov, Mitko
Guthy, Daniel
Sterker, Dario
McSheehy, Paul
License valid from 2017-08-04